Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Aug
6
2024
 Ohio Now Has Legal Recreational Marijuana: What Employers Need to Know Barnes & Thornburg LLP
Aug
6
2024
 Unpacking Averages: Is It Too Soon to Study the Postmarket Experience of AI-Driven Medical Devices? Epstein Becker & Green, P.C.
Aug
6
2024
 FDA to Hold Public Meeting on Post-Market Chemical Assessment Keller and Heckman LLP
Aug
5
2024
 Medicare Part D Preemption: Supreme Court Review Uncertain Squire Patton Boggs (US) LLP
Aug
5
2024
 Longevity Series: Dipping Our Toes in the Fountain of Youth: An Introduction into Longevity Research Womble Bond Dickinson (US) LLP
Aug
5
2024
 Food & Chemicals Unpacked: Economic Adulteration: Secrets in the Sauce [Podcast] Keller and Heckman LLP
Aug
3
2024
 FDA Gives Companies a New Way to Fight Misinformation McDermott Will & Emery
Aug
2
2024
 Olive Oil Fraud and Mislabeling Cases in EU Hit Record High Keller and Heckman LLP
Aug
2
2024
 Precision Lens Pays $12 Million to Resolve FCA and AKS Violations ArentFox Schiff LLP
Aug
2
2024
 Beer and Liquor Lobbies Quarrel Over Tax Policies While Facing TCJA Sunset Jones Walker LLP
Aug
1
2024
 2024 Mid-year Employment Law Updates Polsinelli PC
Aug
1
2024
 Current Trends in Legislation – June & July 2024 CMBG3 Law
Aug
1
2024
 FDA: The Effects of Loper on the Regulatory Agenda Foley & Lardner LLP
Aug
1
2024
 2024 Title Insurance Financial Survey/Overview ArentFox Schiff LLP
Aug
1
2024
 Diagnosing Health Care Podcast: The DEA Is Knocking at Your Door . . . Are You Prepared? [Podcast] Epstein Becker & Green, P.C.
Aug
1
2024
 Sponsor’s Role in Regulatory Testing — A Conversation with Lara Hall [Podcast] Bergeson & Campbell, P.C.
Jul
31
2024
 PBM Policy and Legislative Update — Summer 2024 Mintz
Jul
31
2024
 The Supreme Court of Justice Confirms Relevant Criteria Related to The Legal Standing to Claim the Invalidity of A Pharmaceutical Patent. OLIVARES
Jul
31
2024
 NREL Releases Parts 1 and 2 of SAF State-of-Industry Report Bergeson & Campbell, P.C.
Jul
31
2024
 This Week in 340B: July 23 – 29, 2024 McDermott Will & Emery
Jul
30
2024
 2024 NIOSH Nanotechnology Health and Safety Summit Will Be Held October 9-10, 2024 Bergeson & Campbell, P.C.
Jul
30
2024
 2024 Agile BioFoundry Industry Day Will Be Held September 12, 2024 Bergeson & Campbell, P.C.
Jul
30
2024
 FDA’s Second Untitled Letter of the Year – An Apparently Tough Choice Between Raising Awareness and Public Safety for Anaphylaxis Drugs Sheppard, Mullin, Richter & Hampton LLP
Jul
30
2024
 USDA Publishes Proposed Rule to Reduce Salmonella in Poultry Products Keller and Heckman LLP
Jul
30
2024
 After Loper Bright, Should the FTC's Views on Advertising Interpretation Still Receive Deference? Katten
Jul
29
2024
 Biotechnology Regulatory Services Will Hold Annual Stakeholder Meeting on November 14, 2024; Stakeholders Can Suggest Topics until September 13 Bergeson & Campbell, P.C.
Jul
29
2024
 Challenges to LDT Final Rule Continue as Rule Goes into Effect Polsinelli PC
Jul
29
2024
 FDA Guidance on DSCSA Small Dispenser Exemption and Exemptions and Waivers for Other Trading Partnersv Epstein Becker & Green, P.C.
Displaying 365 - 392 of 11742
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins